Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Working Group on Thrombosis. Discover your benefits and join us!
Pharmacology Catholic University School Of Medicine
Rome - Italy
Biography:Bianca Rocca, MD, PhD is Professor of Pharmacology at the Catholic University School of Medicine in Rome (Italy). Prof. Rocca trained as Postdoctoral Fellow at the Center for Experimental Therapeutics, University Pennsylvania of Philadelphia (USA) with Prof. Garret A. FitzGerald. Prof. Rocca is member of the Editorial Board of the 'European Heart Journal-Cardiovascular Pharmacology’, listed in the Top Italian Scientists, has co-authored over 100 articles with over 5000 citations in peer-reviewed journals, including: Nature Medicine, Science, Blood, Circulation, Journal of Clinical Investigation, PNAS (USA), Annals of Internal Medicine, ATVB, Nature Clinical Practice in Cardiovascular Medicine, JACC, European Heart Journal, Diabetes. Her H-index is 36. Main scientific interests are: eicosanoids, antiplatelet drugs, cardiovascular prevention, non-steroidal anti-inflammatory drugs, cardiovascular disorders.
Oberarzt, Medizinische Klinik und Poliklinik ILudwig-Maximilians-Universität (LMU) München Medizinische Klinik I
Biography:Dirk Sibbing, MD, FESC, MHBA is Professor of Cardiology at the Ludwig-Maximilians University (LMU) in Munich. Prof. Sibbing trained and worked as fellow at the Deutsches Herzzentrum München from 2004-2012 under Prof. Albert Schömig and Prof. Adnan Kastrati. Since 2012 he works in his current position as senior doctor and interventional cardiologist at the department of cardiology at LMU Munich (Head of institution: Prof. Steffen Massberg), where he also leads the study group on drugs in cardiovascular disease. Prof. Sibbing is section editor of the journal Thrombosis & Haemostasis, is listed among the 50 most frequently cited cardiovascular researchers in the German speaking area and has (co)-authored >100 articles with over 4500 citations in peer-reviewed journals, including: The Lancet, JACC, Circulation, European Heart Journal and Thrombosis & Haemostasis. His H-index is 30 and his main scientific interests are: coronary interventions, antiplatelet drugs, platelet function monitoring and genetics of cardiovascular disorders.
Cardiology Division, Sto andre Hospital
Leiria – Portugal
Biography:João Morais, MD, PhD, is Head of Cardiology Division and Coordinator of the Research Centre of Leiria Hospital Centre in Portugal. He is Affiliated Professor in Oporto Medical School. He is Elect President of the Portuguese Society of Cardiology. Prof. Morais authored and co-authored more than 220 papers, half of them published in full-text in peer review journals. He was invited speaker in more than 400 national and international meetings. As an investigator, he participated in more than 50 international clinical trials, registries and other scientific projects, being member of the Steering Committee and National Leader in 20. In 2014, prof. Morais was awarded by the Mayor of Leiria with the city's Silver Medal regarding highly relevant services in health care.
Catalan Institute of Cardiovascular Sciences
Hospital Santa Creu and Sant Pau
Barcelona - Spain email
Biography:Gemma Vilahur, PhD is a Senior I3P Researcher at the Catalan Institute of Cardiovascular Sciences (ICCC; Hospital Santa Creu and Sant Pau) in Barcelona, where she coordinates the Translational Research Department since her return from the United States in 2006. She is PI and Co-PI of multiple grants/projects (National and European) either funded by the Government or the Industry. Her research activities have been focused on cardiovascular research, especially devoting to elucidate the basic mechanisms underlying vascular and heart disease pathology (from atherothrombosis to ischemic heart disease) and to discover and evaluate new potential therapeutic targets/approaches. She has published 94 peer-reviewed articles (1581 citations; H=24), has contributed to more than 28 book chapters, is co-author of several patents and has received many scientific awards.
Bologna - Italy
Biography:Andrea Rubboli, MD, FESC is senior interventional and clinical cardiologist at the Division of Cardiology, Ospedale Maggiore, Bologna, Italy. His clinical activity is mainly devoted to the interventional management of patients with coronary artery disease, and especially acute coronary syndromes. His research interest has long been focused on thromboembolic disease, both at the venous and arterial site. In particular, he has carried out pioneering research on the management of patients on oral anticoagulation undergoing percutaneous coronary intervention. In this field, he has been providing a substantial amount of data, has chaired or co-chaired National and International research projects, and has participated in the development of consensus documents issued by Scientific Societies. Dr. Rubboli has authored/co-authored >100 articles with over 2000 citations in peer-reviewed journals.
Biography:Bruna Gigante, MD has been appointed associate professor in epidemiology at the Unit of Cardiovascular Epidemiology at the Institute of Environmental Medicine (IMM) at Karolinska Institutet (KI) and as deputy senior registry at the Department of Cardiology at Danderyd Hospital. She has authored/co-authored 95 scientific publications in peer-reviewed international journals. Overarching aim of her research line is the discovery and validation of biomarkers that can be used as independent predictors of cardiovascular events and as novel target for treatment.
London, United Kingdom
Biography:Diana Gorog MB BS, MD, PhD, FRCP is a Consultant Cardiologist and Clinical Director of Research at East and North Hertfordshire NHS Trust, and Visiting Professor at University of Hertfordshire (United Kingdom). Prof. Gorog trained in medicine at St. Bartholomew’s Medical School, University of London, and undertook her cardiology training in central London teaching hospitals. She obtained a postgraduate MD from Imperial College and PhD from King’s College, London. In addition to being an interventional cardiologist, including undertaking PPCI on call, she is actively engaged in clinical research on thrombosis, in particular platelet function testing, endogenous fibrinolysis and thrombosis risk assessment. She has published >80 papers, including in Nature Reviews Cardiology, JACC and European Heart Journal.
Aarhus - Denmark
Biography:Erik Lerkevang Grove, MD, PhD has specialised in Internal Medicine: Cardiology and in Thrombosis & Haemostasis. He is a clinical cardiologst at Aarhus University Hospital in Denmark and has a PhD in platelet function testing and platelet turnover in coronary artery disease. He works in a thrombosis clinic and also with cardiac CT. Other areas of interest include antithrombotic therapy, acute cardiac care, diabetes mellitus, atrial fibrillation and oral anticoagulants, including warfarin, self-monitored anticoagulant therapy, non-vitamin K-antagonist oral anticoagulants, switching, and drug-drug interactions. His research include laboratory studies, clinical studies and registry-based pharmaco-epidemiology.
Vienna - Austria
Biography:Jolanta Siller-Matula, MD, PhD is a clinical cardiologist and associate professor at the Department of Cardiology at the Medical University of Vienna, Austria. Her research focuses on arterial thrombosis, personalized antiplatelet therapy and antithrombotic therapy. Her publications (70 peer-reviewed articles) have added to a debate in the cardiology community surrounding the efficacy and safety of conventional antiplatelet treatment. In particular, she described the link between high platelet reactivity and ischemic risk, and the effect of genetic polymorphisms and drug-drug interactions on the pharmacodynamics of antiplatelet drugs and clinical outcomes in patients with cardiovascular disease.
Biography:Associate Professor Dr. Walter Speidl is clinical cardiologist and intensivist at the Medical University of Vienna in Austria. He is working as deputy chair of the medical intensive care unit and as interventionist. His clinical research focuses on biomarker of inflammation and thrombosis in stable coronary artery disease and acute coronary syndromes. In addition, he devotes his time on basic research regarding the interplay of innate immunity and thrombosis in the pathogenesis of atherosclerosis and acute coronary events. His utmost interest is the bridge between basic and clinical science in these fields of cardiology.
Oslo - Norway
Biography:Sigrun Halvorsen, MD, PhD, FESC is Professor at the University of Oslo and Head of the Department of Cardiology, Oslo University Hospital Ulleval. After defending her Thesis in the field of basic coagulation and fibrinolysis, she has continued with clinical research on antithrombotic treatment and treatment of acute myocardial infarction, and has published over 100 scientific papers with over 8000 citations in peer-reviewed journals. She has also participated in several ESC Clinical Practice Guidelines, been actively involved in several ESC Working groups, and been an ordinary Nucleus Member of the ESC Working Group on Thrombosis from 2012 to 2016.
Paris - France
Biography:Professor Jean-Philippe Collet is the Director of Interventional Cardiology at the Institut de Cardiologie of the Pitié-Salpêtrière University Hospital in Paris where he works as a practicing interventional cardiologist (PCI and TAVI). His main expertise is in the field of acute coronary syndrome and intervention for valvular heart disease with a special focus in thrombosis, from pathogenesis to therapeutics. Dr Collet’s clinical research is focused on the effect of antithrombotic agents in ACS, PCI and TAVI. He has been a pioneer in the field of thrombus structural properties but also in the pharmacogenetic of clopidogrel treatment and platelet function testing. He is a member and a founder of the Academic Research Organisation A.C.T.I.O.N (Alliés in Cardiovascular Trials, Initiatives and Organized Networks) (www.action-coeur.org). He has been the principal investigator of several randomized trials (DOSAPI, ARCTIC) and is now leading the ATLANTIS trial on antithrombotics in post-TAVI. Jean-Philippe Collet is a Fellow of the European Society of Cardiology and serves as an active member of the nucleus of the Working Group on Thrombosis and the Committee for Practice Guidelines.
Sheffield - United Kingdom
Biography:Robert Storey is Professor of Cardiology at the University of Sheffield, Sheffield, UK, where he has headed a thrombosis research group since 2002. He is also Academic Director and honorary Consultant Cardiologist for the Cardiology and Cardiothoracic Surgery Directorate, Sheffield Teaching Hospitals NHS Foundation Trust. He has a special interest in the management of ischaemic heart disease, including acute coronary syndromes and coronary intervention. He has been a Task Force member for ESC guidelines on non-ST-elevation acute coronary syndromes and dyslipidaemias. He served as a member of the executive committees for the DISPERSE2, PLATO and PEGASUS-TIMI 54 studies, leading the platelet function substudies for these trials, and of the steering committees for the TRA-CER, EPICOR and ATLANTIC studies. He is currently a member of the steering committees for the COMPLETE, RAPID CTCA and SENIOR RITA studies.
Working Group representative for CBCS
Biography:Johann Wojta, PhD, is Associate Professor of Medical Physiology at the Medical University of Vienna, Head of Research at the Division of Cardiology and Head of Core Facilities. He obtained his PhD in Zoology in 1986 at the University of Vienna and since then has done research in the area of cardiovascular biology with a focus on atherosclerosis. He has published more than 270 papers in peer-reviewed journals and he has a Hirsh-index of 41. He has been Nucleus Member of the ESC Working Group on Thrombosis from 2010 to 2014, an ex-officio Nucleus Member from 2015 to 2016 and will be an affiliated Nucleus Member from 2017 to 2018.
© 2017 European Society of Cardiology. All rights reserved